Articles From: Heartland School Solutions Launches mySchoolBucks(R) Mobile Application to Heat Biologics, Inc. Reports 2013 Fourth Quarter and Full Year Financial Results


2013/8/12
http://media.marketwire.com/attachments/201202/20270_HPSlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1041295&ProfileId=051205&sourceType=1 PRINCETON, NJ --
Sign-up for Heartland School Solutions Launches mySchoolBucks(R) Mobile Application investment picks
2014/2/3
(NASDAQ:AMZN) – With Valentine's Day just around the corner, Amazon.com today announced its list of the Top 20 Most Romantic Cities in the U.S. The cities were determined by compiling sales data of romance novels and relationship books (both Kindle and print); romantic comedy movies (digital and DVDs); a collection of romantic music, including Dean Martin, Barry White, Luther Vandross, Maxwell and Miguel (CDs and MP3s); as well as the sales of sexual wellness products, among cities with more than 100,000 residents.
Sign-up for Hearts are on Fire in San Antonio and Seattle – Amazon.com Announces the Top 20 Most Romantic Cities in the U.S. investment picks
2014/1/14
Fourth Quarter 2013 Revenues Approximately $53 Million; up 62% from Q4 in 2012; 2013 Preliminary Revenues Approximately $208 Million; 87% increase from 2012 FRAMINGHAM, Mass.
Sign-up for HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues investment picks
- U.S. Revenues of $25.1 million, up from $4.2 million in Second Quarter of 2012; Reflects Strong Initial Commercialization of HVAD® Pump in U.S. - - Conference call today at 8:00 a.m. U.S. E.T. - FRAMINGHAM, Mass.
Sign-up for HeartWare International Reports $50.8 Million In Second Quarter 2013 Revenue; 75% Increase From Second Quarter Of 2012 investment picks
- Strong continued adoption of HeartWare® System within U.S. commercial launch results in domestic revenue of $28.2 million, up 12% sequentially from Second Quarter of 2013; - International Revenue of $26.6 million, up 38% from Third Quarter of 2012; Bolstered by European Market Strength FRAMINGHAM, Mass.
Sign-up for HeartWare International Reports $54.8 Million In Third Quarter 2013 Revenue; 140% Increase From Third Quarter Of 2012 investment picks
2014/2/27
- U.S. revenue increased 94% in fourth quarter 2013 to $25.9 million, from $13.4 million in fourth quarter of 2012 - Revenue for 2013 increased 87% to $208 million from $111 million in 2012, reflects first year of commercialization in U.S. - Conference call today at 8:00 a.m. U.S. EST - FRAMINGHAM, Mass.
Sign-up for HeartWare International Reports Fourth Quarter 2013 Results investment picks
2014/3/7
FRAMINGHAM, Mass.
Sign-up for HeartWare Presentation At The 2014 Barclays Global Healthcare Conference To Be Webcast investment picks
2014/2/4
FRAMINGHAM, Mass.
Sign-up for HeartWare Presentation At The 2014 Leerink Global Healthcare Conference To Be Webcast investment picks
2013/11/25
FRAMINGHAM, Mass.
Sign-up for HeartWare Presentation At The 25th Annual Piper Jaffray Healthcare Conference To Be Webcast investment picks
2013/11/5
FRAMINGHAM, Mass.
Sign-up for HeartWare Presentation At The Credit Suisse Healthcare Conference To Be Webcast investment picks
2013/12/6
FRAMINGHAM, Mass.
Sign-up for HeartWare Presentation At The Oppenheimer 24th Annual Healthcare Conference To Be Webcast investment picks
2014/2/26
FRAMINGHAM, Mass.
Sign-up for HeartWare Presentation At The Raymond James 35th Annual Institutional Investors Conference To Be Webcast investment picks
2013/8/27
- Amended protocol includes enhanced blood pressure monitoring to ensure optimal patient management - FRAMINGHAM, Mass.
Sign-up for HeartWare Receives FDA Approval To Enroll Supplemental Patient Cohort In Destination Therapy Trial investment picks
2014/2/4
FRAMINGHAM, Mass.
Sign-up for HeartWare Schedules Fourth Quarter Conference Call And Webcast investment picks
2013/10/25
FRAMINGHAM, Mass.
Sign-up for HeartWare Schedules Third Quarter Conference Call And Webcast investment picks
2013/12/1
- Acquisition expands HeartWare's technology platform into partial support for less sick patients - - Investor Conference Call on Monday, December 2, 2013 at 8:00 a.m. U.S. EST - FRAMINGHAM, Mass.
Sign-up for HeartWare® International Announces Acquisition Of CircuLite®, Inc. investment picks
http://media.marketwire.com/attachments/201309/66254_HeatBiologo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1078773&ProfileId=051205&sourceType=1 CHAPEL HILL, NC --
Sign-up for Heat Biologics Announces Its Phase 1/2 Study of HS-410 in Bladder Cancer Is Open for Enrollment investment picks
2013/9/25
http://media.marketwire.com/attachments/201309/66254_HeatBiologo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1054122&ProfileId=051205&sourceType=1 CHAPEL HILL, NC --
Sign-up for Heat Biologics Appoints Louis C. Bock to Board of Directors investment picks
2014/3/3
http://media.marketwire.com/attachments/201402/71056_heatbiologics.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1094397&ProfileId=051205&sourceType=1 CHAPEL HILL, NC --
Sign-up for Heat Biologics Commences Dosing of First Patient in Phase 1/2 Study of Novel Cancer Immunotherapy Product Candidate HS-410 for the Treatment of Bladder Cancer investment picks
2013/11/25
http://media.marketwire.com/attachments/201309/66254_HeatBiologo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1071376&ProfileId=051205&sourceType=1 CHAPEL HILL, NC --
Sign-up for Heat Biologics Successfully Completes Manufacturing of HS-410 to Start Phase 1/2 Bladder Cancer Trial investment picks
2014/2/3
http://media.marketwire.com/attachments/201402/71056_heatbiologics.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1086576&ProfileId=051205&sourceType=1 CHAPEL HILL, NC --
Sign-up for Heat Biologics, Inc. Announces Formation of Clinical Advisory Board With Preeminent Immunotherapy and Oncology Experts investment picks
2013/8/13
http://media.marketwire.com/attachments/201307/64032_heatbiologic.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1042469&ProfileId=051205&sourceType=1 CHAPEL HILL, NC --
Sign-up for Heat Biologics, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option investment picks
2013/9/4
http://media.marketwire.com/attachments/201307/64032_heatbiologic.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1048077&ProfileId=051205&sourceType=1 CHAPEL HILL, NC --
Sign-up for Heat Biologics, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option investment picks
2013/12/17
http://media.marketwire.com/attachments/201309/66254_HeatBiologo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1076781&ProfileId=051205&sourceType=1 CHAPEL HILL, NC --
Sign-up for Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development investment picks
2014/3/5
http://media.marketwire.com/attachments/201402/71056_heatbiologics.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1095004&ProfileId=051205&sourceType=1 CHAPEL HILL, NC --
Sign-up for Heat Biologics, Inc. Appoints Taylor H. Schreiber, M.D., PH.D. as Vice President of Research and Development investment picks
2014/4/9
http://media.marketwire.com/attachments/201404/73920_heatlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1105362&ProfileId=051205&sourceType=1 CHAPEL HILL, NC --
Sign-up for Heat Biologics, Inc. Presents Proprietary Allogeneic Cell Line Antigen Screening Algorithm and Systematic Analysis of Combination Tumor Immunotherapy Preclinical Data at the 105th Annual Meeting of the American Association for Cancer Research investment picks
2014/4/1
http://media.marketwire.com/attachments/201403/73497_heatlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1102861&ProfileId=051205&sourceType=1 CHAPEL HILL, NC --
Sign-up for Heat Biologics, Inc. Reports 2013 Fourth Quarter and Full Year Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Heartland School Solutions Launches mySchoolBucks(R) Mobile Application to Heat Biologics, Inc. Reports 2013 Fourth Quarter and Full Year Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity